IMPURITIES AVAILABLE FOR 'Afatinib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Afatinib. Afatinib is an oral, irreversible tyrosine kinase inhibitor (TKI) used primarily for the treatment of non-small cell lung cancer (NSCLC) with EGFR (epidermal growth factor receptor) mutations. It blocks the signaling pathways of EGFR, HER2, and HER4, thereby inhibiting cancer cell proliferation and survival. Afatinib is particularly effective against tumors harboring common EGFR mutations such as exon 19 deletions and exon 21 (L858R) substitutions. It is taken once daily and is used as first-line therapy in eligible patients. Common side effects include diarrhea, rash, stomatitis, and paronychia. Dose adjustments may be required to manage toxicity. Regular monitoring of liver and renal function is advised during treatment. Buy high quality Afatinib from Omsynth Lifesciences.